Extracorporeal Membrane Oxygenation, Nitric Oxide, Tracheal Intubation, Ventilator-induced Diaphragmatic Dysfunction
Conditions
Keywords
ventilator-induced diaphragm dysfunction, nitric oxide, extracorporeal membrane oxygenation, oxidative stress, endoplasmic reticulum stress
Brief summary
The goal of this clinical trial is to explore the effect of NO treatment on diaphragm function after mechanical ventilation with ECMO assistance. We expect to enroll a total of 80 patients who will receive mechanical ventilation and mechanical ventilation combined with ECMO treatment. Depending on the indication, they will be given NO treatment or not. In ECMO assisted mechanical ventilation + NO treatment group, the subjects will be randomly assigned to NO treatment via ventilator or membrane oxygenator. The main questions it aims to answer are: 1. Observing the influences and potential therapeutic effects of different NO insertion methods through ventilator or membrane oxygenator on the occurrence and development of ventilator-induced diaphragm (VIDD) dysfunction during ECMO assisted mechanical ventilation. 2. Exploring the potential key molecular mechanisms of NO treatment on the occurrence and development of VIDD after ECMO assisted mechanical ventilation.
Interventions
DRUGNitric Oxide
Depending on the indication, the subjects will be given NO treatment or not. In ECMO assisted mechanical ventilation + NO treatment group, the subjects will be randomly assigned to NO treatment via ventilator or membrane oxygenator.
Sponsors
Zhongnan Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age ≥ 18 years; 2. Tracheal intubation in our emergency department; 3. Expected survival time ≥ 72 hours; 4. Family members agree to participate and sign the informed consent form.
Exclusion criteria
1. Pregnant women; 2. Patients with diaphragmatic hernia or other known diaphragmatic diseases and injuries; 3. Patients with mechanical ventilation treatment within 3 months; 4. Thoracic or abdominal tumor invading the diaphragm; 5. A large amount of ascites raises the diaphragm position; 6. Upper respiratory tract malformation; 7. Trauma leading to chest collapse, etc.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diaphragm function | We starts POCUS within 1 hour (1h) after mechanical ventilation, and continuously monitoring the diaphragm function at 6h, 12h, 24h, 48h, 72h, 96h, 120h, 144h and 168h respectively. POCUS will be terminated if the patient dies. | Continuous POCUS monitoring of diaphragm function during mechanical ventilation, including diaphragm thickness, diaphragm thickening fraction, diaphragm excursion, etc |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Inflammatory cytokines | The fixed time point on the 1st, 2nd, 3rd, 4th, 5th, 6th and 7th day. | TNF - α, IL-1β , IL-6, IL-8, IL-10, etc. |
| Oxidative stress markers | The fixed time point on the 1st, 2nd, 3rd, 4th, 5th, 6th and 7th day. | ROS, SOD, MDA, GSH, etc. |
Countries
China
Outcome results
None listed